NASDAQ
Greenwich LifeSciences, Inc. (GLSI) has a current ratio of 2.62x as of Monday, May 25, 2026. This represents a 93.93% decrease compared to its 12-month average of 43.25x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.